Yahoo
NYSE - Nasdaq Real Time Price USD

Inspire Medical Systems, Inc. (INSP)

61.66 -1.33 (-2.11%)
As of 10:49:10 AM EDT. Market Open.
Trade INSP on Coinbase
Chart Range Bar
Loading chart for INSP
  • Previous Close 62.99
  • Open 63.00
  • Bid 61.60 x 10000
  • Ask 61.95 x 40000
  • Day's Range 61.66 - 63.31
  • 52 Week Range 38.91 - 147.03
  • Volume 64,278
  • Avg. Volume 875,312
  • Market Cap (intraday) 1.783B
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) 13.61
  • EPS (TTM) 4.53
  • Earnings Date (est.) Nov 2, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 60.40

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

www.inspiresleep.com

1,333

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INSP
33.15%
S&P 500 (^GSPC)
11.81%

1-Year Return

INSP
34.19%
S&P 500 (^GSPC)
18.47%

3-Year Return

INSP
74.19%
S&P 500 (^GSPC)
69.49%

5-Year Return

INSP
72.51%
S&P 500 (^GSPC)
69.17%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 200.58M
Earnings 314k
Profit Margin 0.16%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
50M
100M
150M
200M
250M
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%

Analyst Insights

View More

Analyst Price Targets

40.00 Low
60.40 Average
61.66 Current
85.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/4/2026
Analyst JP Morgan
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 54 -> 60

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    1.76B

  • Enterprise Value

    1.47B

  • Trailing P/E

    13.43

  • Forward P/E

    1.11k

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.99

  • Price/Book (mrq)

    2.13

  • Enterprise Value/Revenue

    1.63

  • Enterprise Value/EBITDA

    17.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.03%

  • Return on Assets (ttm)

    3.91%

  • Return on Equity (ttm)

    17.97%

  • Revenue (ttm)

    898.74M

  • Net Income Avi to Common (ttm)

    135.04M

  • Diluted EPS (ttm)

    4.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    320.68M

  • Total Debt/Equity (mrq)

    3.52%

  • Levered Free Cash Flow (ttm)

    94.64M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

61.66 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Raising target price to $58.00

    INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $58.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
  • Lowering target price to $55.00

    INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $55.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
  • Lowering target price to $56.00

    INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $56.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
  • Raising target price to $61.00

    INSPIRE MEDICAL SYSTEMS INC has an Investment Rating of HOLD; a target price of $61.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: